Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company developing AI-powered, incision-free therapies for ablating diseased tissue, anno ...
CINCINNATI (WKRC) — A groundbreaking procedure is offering new hope for men suffering from benign prostate hyperplasia (BPH), a condition affecting up to half of all men. Keith Neer, a patient who ...
LAS VEGAS -- A novel, non-ablative intervention for lower urinary tract symptoms (LUTS) produced rapid, durable symptom relief with no adverse effect on sexual function, long-term results from ...
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
DEAR MAYO CLINIC: Recently, I was diagnosed with BPH. This is all new to me, and I hope you can help me better understand the condition and how it's treated. ANSWER: Now that you've been diagnosed ...
Dublin, Dec. 13, 2017 (GLOBE NEWSWIRE) -- The "US Benign Prostatic Hyperplasia (BPH) Procedures Analysis and Forecast to 2023" report has been added to Research and Markets' offering. Increasing ...
Study findings have implications for biopsy-free radical prostatectomy. Combining PSMA-PET and mpMRI results to diagnose clinically significant prostate cancer while excluding benign prostatic ...
The global prostate health market size was US$ 32.83 billion in 2021. The global prostate health market size is forecast to reach US$ 69.70 billion by 2030, growing at a compound annual growth rate ...
Testosterone Gel Findings from a large randomized trial could facilitate decision-making regarding treatment for hypogonadism. Findings from a randomized placebo-controlled trial may help inform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback